Marshall Wace, LLP Uni Qure N.V. Transaction History

Marshall Wace, LLP

  • $77.3 Billion
  • Q3 2024

A detailed history of Marshall Wace, LLP transactions in Uni Qure N.V. stock. As of the latest transaction made, Marshall Wace, LLP holds 1,125,656 shares of QURE stock, worth $6.42 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
1,125,656
Previous 39,078 2780.54%
Holding current value
$6.42 Million
Previous $175,000 3070.86%
% of portfolio
0.01%
Previous 0.0%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024
BUY
$3.78 - $10.12 $4.11 Million - $11 Million
1,086,578 Added 2780.54%
1,125,656 $5.55 Million
Q2 2024

Aug 14, 2024
BUY
$4.39 - $5.43 $171,552 - $212,193
39,078 New
39,078 $175,000
Q3 2023

Nov 14, 2023
BUY
$6.71 - $11.83 $143,238 - $252,535
21,347 New
21,347 $143,000
Q1 2023

May 15, 2023
BUY
$18.7 - $23.07 $354,252 - $437,038
18,944 New
18,944 $381,000
Q2 2022

Aug 15, 2022
BUY
$13.15 - $20.45 $6.49 Million - $10.1 Million
493,179 Added 671.3%
566,645 $10.6 Million
Q2 2021

Aug 13, 2021
BUY
$29.97 - $37.17 $2.2 Million - $2.73 Million
73,466 New
73,466 $2.26 Million
Q1 2021

May 17, 2021
SELL
$29.24 - $42.03 $20.5 Million - $29.5 Million
-701,084 Closed
0 $0
Q4 2020

Feb 16, 2021
SELL
$35.35 - $50.67 $29.6 Million - $42.4 Million
-836,821 Reduced 54.41%
701,084 $25.3 Million
Q3 2020

Nov 16, 2020
BUY
$35.98 - $47.66 $26.6 Million - $35.2 Million
737,928 Added 92.24%
1,537,905 $56.6 Million
Q2 2020

Aug 13, 2020
BUY
$45.06 - $67.74 $35.3 Million - $53.1 Million
783,344 Added 4709.58%
799,977 $36 Million
Q1 2020

May 15, 2020
SELL
$40.01 - $73.97 $494,563 - $914,343
-12,361 Reduced 42.63%
16,633 $789,000
Q4 2019

Feb 14, 2020
SELL
$37.13 - $74.62 $14 Million - $28.1 Million
-376,974 Reduced 92.86%
28,994 $2.08 Million
Q3 2019

Nov 14, 2019
BUY
$39.36 - $76.8 $10.5 Million - $20.5 Million
266,995 Added 192.12%
405,968 $16 Million
Q2 2019

Aug 14, 2019
BUY
$52.76 - $82.19 $7.33 Million - $11.4 Million
138,973 New
138,973 $10.9 Million
Q1 2019

May 14, 2019
SELL
$27.39 - $68.41 $94,742 - $236,630
-3,459 Closed
0 $0
Q4 2018

Feb 14, 2019
BUY
$22.8 - $33.93 $78,865 - $117,363
3,459 New
3,459 $100,000

Others Institutions Holding QURE

# of Institutions
153
Shares Held
41M
Call Options Held
925K
Put Options Held
617K
View Full List

About uniQure N.V.

QURE Quotes by TradingView
  • Ticker QURE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 46,729,100
  • Market Cap $266M
  • Description
  • uniQure N.V., a gene therapy company, engages in the development of treatments for patients suffering from genetic and other devastating diseases. Its lead program is Etranacogene dezaparvovec (AMT-061), which is in Phase III HOPE-B pivotal trial for the treatment of hemophilia B. The company also engages in developing AMT-130, a gene therapy th...
More about QURE
Track This Portfolio

Track Marshall Wace, LLP Portfolio

Follow Marshall Wace, LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Marshall Wace, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Marshall Wace, LLP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email